Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated falciparum malaria in Sudan
ACTRN12622000930785Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in malaria and Falciparum malaria (PF), sponsored by Ministry of Health. Primary endpoints: Percent of treatment failures and Adequate clinical and parasitological response. Started Dec 2017; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12622000930785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000930785.